Citigroup’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,624
| Closed | -$12.1K | – | 4970 |
|
|
2023
Q4 | $12.1K | Sell |
1,624
-3,643
| -69% | -$27.1K | ﹤0.01% | 4383 |
|
|
2023
Q3 | $30.3K | Buy |
+5,267
| New | +$30.3K | ﹤0.01% | 3589 |
|
|
2022
Q3 | – | Sell |
-9
| Closed | – | – | 5537 |
|
|
2022
Q2 | $0 | Sell |
9
-244
| -96% | – | ﹤0.01% | 5839 |
|
|
2022
Q1 | $5K | Buy |
253
+8
| +3% | +$158 | ﹤0.01% | 5029 |
|
|
2021
Q4 | $15K | Buy |
245
+125
| +104% | +$7.65K | ﹤0.01% | 4711 |
|
|
2021
Q3 | $11K | Buy |
120
+74
| +161% | +$6.78K | ﹤0.01% | 4692 |
|
|
2021
Q2 | $8K | Sell |
46
-12
| -21% | -$2.09K | ﹤0.01% | 5070 |
|
|
2021
Q1 | $11K | Buy |
+58
| New | +$11K | ﹤0.01% | 4940 |
|